Predict your next investment

Cerevast Therapeutics company logo
HEALTHCARE | Medical Devices & Equipment / Therapeutic Devices
cerevast.com

See what CB Insights has to offer

Total Raised

$23.32M

Investors Count

4

Deal Terms

2

Cerevast Therapeutics Funding, Cerevast Therapeutics Valuation & Cerevast Therapeutics Revenue

9 Fundings

Cerevast Therapeutics's latest funding round was a Series D for $10M on December 25, 2014.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

12/25/2014

Series D

$10M

$0.00B

((9.99x))

FY 1234

4

11/25/2013

Debt - III

$99M

$0.00B

((9.99x))

FY 1234

10

4/22/2013

Series C - II

$99M

$0.00B

((9.99x))

FY 1234

10

12/12/2011

Series C

$99M

$0.00B

((9.99x))

FY 1234

10

10/14/2011

Debt - II

$99M

$0.00B

((9.99x))

FY 1234

10

Date

12/25/2014

11/25/2013

4/22/2013

12/12/2011

10/14/2011

Round

Series D

Debt - III

Series C - II

Series C

Debt - II

Amount

$10M

$99M

$99M

$99M

$99M

Investors

Valuation

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

4

10

10

10

10

Cerevast Therapeutics Deal Terms

2 Deal Terms

Cerevast Therapeutics's deal structure is available for 2 funding rounds, including their Series B from January 08, 2010.

Round

Series B

Series A

Funding Date

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

Board Voting

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B

$99M

$99M

$99M

$99M

Series A

Cerevast Therapeutics Investors

4 Investors

Cerevast Therapeutics has 4 investors. Genstar Capital invested in Cerevast Therapeutics's Series D funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

5/18/2011

12/25/2014

5
Debt, Debt - II (2011), Series C (2011), Series C - II (2013), Series D (2014)

Private Equity

California

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Venture Capital

California

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Venture Capital

China

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Government

DC

First funding

5/18/2011

00/00/0000

00/00/0000

00/00/0000

Last Funding

12/25/2014

00/00/0000

00/00/0000

00/00/0000

Investor

Subscribe to see more

Subscribe to see more

Subscribe to see more

Rounds

5
Debt, Debt - II (2011), Series C (2011), Series C - II (2013), Series D (2014)

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Subscribe to see more

Subscribe to see more

Type

Private Equity

Venture Capital

Venture Capital

Government

Location

California

California

China

DC

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.